Guillain Barre Syndrome Treatment Market
Global Guillain Barre Syndrome Treatment Market Size, Share, and Trends Analysis Report By Type (Intravenous Immunoglobulin, Plasma Exchange, and Others) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global guillain barre syndrome treatment market is anticipated to grow at a significant CAGR of 5.2% during the forecast period 2022-2028. The increasing infections caused by the Epstein–Barr virus, zika virus, and other viruses, as a result of the increased need for treatment. For instance, in 2019, according to the Foundation for Peripheral Neuropathy report, guillain barre syndrome affects about 3,000-6,000 people each year in the US fuelling the demand for effective treatment which is expected to drive the global guillain barre syndrome treatment market during the forecast period. However, the lack of awareness of the disease is factors constraints that are hindering the growth of the global guillain barre syndrome treatment market across the globe.
Impact of COVID-19 Pandemic on Global Guillain Barre Syndrome Treatment Market
The COVID-19 pandemic had a significant impact on the global guillain barre syndrome treatment market. The COVID-19 infection in patients can lead to the development of guillain barre syndrome due to the neurological complication of infection. In order to treat guillain barre syndrome in a COVID-19 patient, guillain barre syndrome treatment has been used heavily, which supported the market to grow. Therapy with IVIG or plasmapheresis was initiated along with antiviral treatment which increased the demand for the drugs and therapeutics during the COVID-19 pandemic. As a result, the market saw an inclination as an impact of COVID-19.
Segmental Outlook
The global guillain barre syndrome treatment market is segmented based on type and distribution channel. Based on the type, the market is sub-segmented into intravenous immunoglobulin, plasma exchange, and others. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and others.
Global Guillain Barre Syndrome Treatment Market Share by Type, 2021 (%)
The Intravenous Immunoglobulin Segment is Anticipated to Hold a Prominent Share in the Global Guillain Barre Syndrome Treatment Market
Intravenous immunoglobulins are expected to account for the significant share of the market, owing to the availability of a wide range of IVIG products such as Gamunex, Gammagard, and Privigen in the market, along with the increased adoption of off-label intravenous immunoglobulin treatment due to the rising prevalence of multifocal motor neuropathy, dermatomyositis, polymyositis, stiff person syndrome, and relapsing-re. Furthermore, the market is expected to be driven by an increase in early regulatory approvals for intravenous immunoglobulin (IVIG) products, and increased government funding to boost plasma production.
Regional Outlooks
The global guillain barre syndrome treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Some factors that are boosting the market growth in the Asia-Pacific region are, improving healthcare infrastructure in the region. Additionally, the increasing government support along with the existence of a large number of players providing effective offerings are some other main factor that is providing support to the growth of the market in the region.
Global Guillain Barre Syndrome Treatment Market Growth, by Region 2022-2028
The North America Region is Estimated to Hold the Major Share in the Global Guillain Barre Syndrome Treatment Market
Throughout the projected period, North America is expected to have significant the global guillain barre syndrome treatment market. The region's significance is attributable to a number of causes, including a rising senior population that is more susceptible to illnesses due to decreasing immunity, resulting in high demand for effective medication. According to research published by the Centers for Disease Control and Prevention (CDC) in December 2019, persons of any age group can develop guillain barre syndrome, however the prevalence of guillain barre syndrome is increasing in people over 50, necessitating a large demand due to the large geriatric population in the US. Furthermore, the presence of major pharmaceutical companies investing in research and development to develop novel products, and regulatory bodies such as the US FDA that raise awareness about the disease and treatment options, are likely to contribute to the market's growth in the region.
Market Players Outlook
Bayer AG, Grifols SA, CSL Ltd., Octapharma AG, Kedrion Biopharma Inc., and Takeda Pharmaceutical Co. Ltd. among others, are some of the leading participants in the global guillain barre syndrome treatment market industry. To increase market share around the globe, these companies are using a variety of techniques, including mergers and acquisitions, product launches, geographic expansion and collaboration, and partnership. For instance, in March 2022, Annexon Biosciences Inc., highlighted that it will present preclinical data supporting complement inhibitor programs for the treatment of Guillain barre syndrome and Huntington's disease at AAN 2022.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Guillain barre syndrome treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Guillain Barre Syndrome Treatment Market
- Recovery Scenario of Global Guillain Barre Syndrome Treatment Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Guillain Barre Syndrome Treatment Market by Type
4.1.1. Intravenous Immunoglobulin
4.1.2. Plasma Exchange
4.1.3. Others (Anticonvulsants and LMWH)
4.2. Global Guillain Barre Syndrome Treatment Market by Distribution Channel
4.2.1. Hospital Pharmacy
4.2.2. Retail Pharmacy
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Akari Therapeutics Inc.
6.2. Annexon Biosciences Inc.
6.3. Bayer AG
6.4. Biotest AG
6.5. China Biologic Product Holdings Inc.
6.6. CSL Ltd.
6.7. CuraVac Inc.
6.8. Grifols SA
6.9. Hansa Medical AB
6.10. Kedrion Biopharma Inc.
6.11. Nihon Pharmaceutical Co. Ltd.
6.12. Octapharma AG
6.13. Takeda Pharmaceutical Co. Ltd.
6.14. Vitality Biopharma Inc.
1. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL INTRAVENOUS IMMUNOGLOBULIN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PLASMA EXCHANGE GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL OTHERS GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
6. GLOBAL HOSPITAL PHARMACY GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL RETAIL PHARMACY GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OTHERS GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
12. NORTH AMERICAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
13. EUROPEAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. EUROPEAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
19. REST OF THE WORLD GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. REST OF THE WORLD GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. REST OF THE WORLD GUILLAIN BARRE SYNDROME TREATMENT MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET, 2021-2028 (%)
4. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL INTRAVENOUS IMMUNOGLOBULIN GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PLASMA EXCHANGE GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL OTHERS GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
9. GLOBAL HOSPITAL PHARMACY GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL RETAIL PHARMACY GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL OTHERS GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL GUILLAIN BARRE SYNDROME TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. US GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
14. CANADA GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
15. UK GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
16. FRANCE GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
19. SPAIN GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF EUROPE GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
21. INDIA GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
22. CHINA GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
23. JAPAN GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF THE ASIA-PACIFIC GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD GUILLAIN BARRE SYNDROME TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
